DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Cannabinol is an investigational drug.
There have been 37 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Vomiting. The leading clinical trial sponsors are Radboud University, Yale University, and National Institute on Drug Abuse (NIDA).
Recent Clinical Trials for Cannabinol
|Cannabis For Cancer-Related Symptoms||Pippa Hawley||Phase 2|
|Evaluation of the Pharmacokinetics of Prana P1 Capsules||The University of The West Indies||Phase 1|
|Effects of THC and Alcohol on Driving Performance||Ontario Ministry of Transportation||Phase 4|